Lipocine (LPCN) Short-term Investments (2015 - 2025)
Lipocine (LPCN) posted Short-term Investments of $9.72 million for Q4 2025, down 37.0% from $15.43 million a year earlier and down 13.4% from the prior quarter.
Analysis
Lipocine (LPCN) Short-term Investments (2015 - 2025) Analysis & Trends
Since Q2 2015, Lipocine has reported Short-term Investments for 43 quarters.
- Annual Short-term Investments has declined for four consecutive years, though with a five-year compound annual growth rate of 84.9% (FY2020 to FY2025).
- In prior years, Lipocine's Short-term Investments was $15.43 million in FY2024 (-10.6%), $17.26 million in FY2023 (-41.2%), $29.38 million in FY2022 (-29.5%) and $41.67 million in FY2021.
- The Q4 2025 figure stands as the lowest quarterly Short-term Investments since Q4 2020.
- On a year-over-year basis, Short-term Investments has declined in each of the last 15 quarters, with an average decline of 22.4% over the last eight quarters.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q2 2021, with growth of 698.7%; the weakest was Q4 2023, with a decline of 41.2%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $11.23 million (Q3 2025), $11.89 million (Q2 2025) and $16.36 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Lipocine | 11.22 Mn | -56.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.72 Mn |
| Sep 30, 2025 | 11.23 Mn |
| Jun 30, 2025 | 11.89 Mn |
| Mar 31, 2025 | 16.36 Mn |
| Dec 31, 2024 | 15.43 Mn |
| Sep 30, 2024 | 16.08 Mn |
| Jun 30, 2024 | 17.00 Mn |
| Mar 31, 2024 | 21.55 Mn |
| Dec 31, 2023 | 17.26 Mn |
| Sep 30, 2023 | 19.78 Mn |
| Jun 30, 2023 | 20.78 Mn |
| Mar 31, 2023 | 24.10 Mn |
| Dec 31, 2022 | 29.38 Mn |
| Sep 30, 2022 | 31.86 Mn |
| Jun 30, 2022 | 32.41 Mn |
| Mar 31, 2022 | 36.27 Mn |
| Dec 31, 2021 | 41.67 Mn |
| Sep 30, 2021 | 34.15 Mn |
| Jun 30, 2021 | 35.67 Mn |
| Mar 31, 2021 | 29.75 Mn |
API Access
Lipocine Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=LPCN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();